Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease

Christophe Rochais, Cédric Lecoutey, Julien Lalut, Audrey Davis, Emilie Duval, Florence Gaven, Stacy Largillière, Gérald Née, Sophie Corvaisier, Jana Sopkova de Oliveira Santos, Marc Since, Thomas Freret, Romain Legrand, Noëlle Callizot, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne

Open source

DOI: 10.1016/j.ejmech.2024.116975
Published: 2024-12
Container: European Journal of Medicinal Chemistry
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2024.116975,
  title = {Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease},
  author = {Christophe Rochais and Cédric Lecoutey and Julien Lalut and Audrey Davis and Emilie Duval and Florence Gaven and Stacy Largillière and Gérald Née and Sophie Corvaisier and Jana Sopkova de Oliveira Santos and Marc Since and Thomas Freret and Romain Legrand and Noëlle Callizot and Sylvie Claeysen and Michel Boulouard and Patrick Dallemagne},
  year = {2024},
  journal = {European Journal of Medicinal Chemistry},
  doi = {10.1016/j.ejmech.2024.116975},
  url = {https://doi.org/10.1016/j.ejmech.2024.116975}
}

RIS

TY  - JOUR
TI  - Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease
AU  - Christophe Rochais
AU  - Cédric Lecoutey
AU  - Julien Lalut
AU  - Audrey Davis
AU  - Emilie Duval
AU  - Florence Gaven
AU  - Stacy Largillière
AU  - Gérald Née
AU  - Sophie Corvaisier
AU  - Jana Sopkova de Oliveira Santos
AU  - Marc Since
AU  - Thomas Freret
AU  - Romain Legrand
AU  - Noëlle Callizot
AU  - Sylvie Claeysen
AU  - Michel Boulouard
AU  - Patrick Dallemagne
PY  - 2024
JO  - European Journal of Medicinal Chemistry
DO  - 10.1016/j.ejmech.2024.116975
UR  - https://doi.org/10.1016/j.ejmech.2024.116975
ER  -

APA

Rochais, C., Lecoutey, C., Lalut, J., Davis, A., Duval, E., Gaven, F., Largillière, S., Née, G., Corvaisier, S., Santos, J. S. D. O., Since, M., Freret, T., Legrand, R., Callizot, N., Claeysen, S., Boulouard, M., & Dallemagne, P. (2024). Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2024.116975

Source records

crossref · retrieved 2026-09-27T10:30:35.844Z